SL Industrial Partners, a member of the Silverman Group, has signed a pre-construction, full-building lease agreement with US Pharma Lab for a 162,657-square-foot build-to-suit facility at the North Brunswick Logistics Center. The building is being custom-built by Silver Line Development, the Silverman Group’s internal general contractor, and will serve as US Pharma Lab’s third New Jersey location. Silver Line is also executing the specialized internal outfitting, which includes custom medical installations such as cleanrooms and precision-controlled environments tailored to US Pharma Lab’s manufacturing needs. Delivery of the facility is expected in fall 2025.
The new US Pharma building is rising at 2 King Arthur Court on the site of a former Johnson & Johnson office building which was razed by Silverman to make way for the modern manufacturing and distribution facility. The North Brunswick Logistics Center is part of the larger SL Corporate Center, situated on the site of the former Johnson & Johnson campus that was acquired by Silverline Windows. The multi-building, multi-use 100-acre campus now features light manufacturing, distribution, office, and warehouse operations, with Cornerstone Building Products as the anchor tenant, occupying over 800,000 square feet.
Headquartered in North Brunswick, NJ, US Pharma Lab is a global leader in developing and manufacturing dietary supplement ingredients and products. The company was attracted to the North Brunswick Logistics Center due to its proximity to the firm’s existing facilities and the convenient commute for employees. The expansion is driven by client business growth, and the new build-to-suit facility will enhance US Pharma Lab’s manufacturing and distribution capabilities.
Blake Silverman, President of The Silverman Group, commented on the significance of the deal: “Securing a full-building, build-to-suit lease with a prestigious company like US Pharma Lab underscores the strategic value of our new project and the quality of industrial space we’re delivering, while also reinforcing New Jersey’s position as a hub for innovative manufacturing and distribution. We’re excited to support US Pharma Lab’s expansion and contribute to the local economy.”
Amol Luhadia, CEO of US Pharma Lab, said: “We are excited to partner with an established developer such as Silverman Group for our next chapter in expanding our growth in the U.S. This collaboration marks a significant milestone, enabling us to create a state-of-the-art built-to-suit facility tailored to our specific needs. With this new facility, we will significantly increase our operational capacity, enhancing our efficiency and responsiveness to better serve our customers. We look forward to working closely with Silverman Group to bring this vision to life.”
The North Brunswick Logistics Center offers direct access to Route 1 via a dedicated underpass, providing both north and southbound connections. The site is also minutes from major highways, including Interstate 95, Interstate 287, and the Garden State Parkway, making it a prime location for logistics and distribution.
Michael Kimmel of KBC Advisors represented US Pharma Lab in the lease transaction, while the landlord was represented by their in-house leasing team.
About SL Industrial Partners
SL Industrial Partners, a member of the Silverman Group family of companies, oversees the leasing and management of 26 million square feet of industrial properties across 21 states, with an additional 15 million square feet of new construction underway in nine states. These projects include both build-to-suit and speculative developments in key emerging markets such as Hartford, CT; Charlotte and Greensboro, NC; Richmond, VA; Savannah and Atlanta, GA; and South Florida.
With a team of dedicated professionals and deep expertise in the industrial real estate sector, SL Industrial Partners is committed to identifying value in the market and providing tenants with facilities designed to support their operational goals. The company’s mission is to deliver top-tier industrial spaces that meet the evolving needs of its clients, ensuring long-term success for all partners involved.
About US Pharma Lab LLC
US Pharma Lab LLC is a global leader in the development, manufacturing, and supply of premium dietary supplement ingredients, premixes, and products. With an emphasis on quality and innovation, US Pharma Lab serves a diverse clientele across multiple industries, helping to shape the future of health and wellness.
In 2023 the company joined Biofarma Group a global full-service CDMO headquartered in Italy and leader in developing, producing and packaging of food supplements, medical devices, probiotic-based drugs and cosmetics. With more than 1.500 employees and 8 manufacturing sites in Europe, America and Asia, Biofarma ensures a truly global offering.
